Jr. Michael Conick Hanley Aeglea Bio Therapeutics, Inc. (AGLE) insider trading activity

AGLE Quotes by TradingView

Jr. Michael Conick Hanley is Chief Business Officer of Aeglea BioTherapeutics, Inc.. Currently has a direct ownership of 36,200 shares of AGLE, which is worth approximately $1 Million. The most recent transaction as insider was on Jun 08, 2022, when has been sold 28,200 shares (Common Stock) at a price of $0.71 per share, resulting in proceeds of $20,022. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.2K
0% 3M change
0% 12M change
Total Value Held $1 Million

Jr. Michael Conick Hanley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 08 2022
BUY
Open market or private purchase
$20,022 $0.71 p/Share
28,200 Added 43.79%
36,200 Common Stock

Also insider at

ANRO
Alto Neuroscience, Inc.
Chief Operating Officer
JMC

Jr. Michael Conick Hanley

Chief Business Officer
Austin, TX

Track Institutional and Insider Activities on AGLE

Follow Aeglea BioTherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGLE shares.

Notify only if

Insider Trading

Get notified when an Aeglea Bio Therapeutics, Inc. insider buys or sells AGLE shares.

Notify only if

News

Receive news related to Aeglea BioTherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGLE